Telangana to position Hyderabad as 'Health-Tech Mecca'
Hyderabad, Feb 24 (IANS) The government of Telangana will work on a programme to position Hyderabad as the "Health-Tech Mecca" of the world, state industries minister K.T. Rama Rao...
Buy
or
Gland News & Analysis
-
-
Gland Pharma to invest Rs 400 cr in Hyderabad's Genome Valley
Hyderabad, Feb 20 (IANS) Gland Pharma (NS:GLAD) on Monday announced that it will invest over Rs 400 crore in Hyderabad's Genome Valley to add capabilities to their existing facility to...
-
This beaten-down stock that has fallen 53% YTD gets a buy call with an upside of up to 42%
Gland Pharma (NS:GLAD) has entered into a put option agreement to acquire a 100% of Cenexi Group for an equity value not exceeding Euro 120 million (Enterprise Value of Euro 230...
-
Stocks Under Focus: Hero Moto, Dabur, Tata Steel, Gland Pharma & More
By Malvika Gurung Investing.com -- Hero MotoCorp (NS:HROM): The world’s leading two-wheeler manufacturer has partnered with Terrafirma Motors to assemble and distribute its vehicles amid...
-
Torrent Pharma Tanks Over 15% Post Q3 Results; 90% Stocks on Nifty Pharma in Red
By Malvika Gurung Investing.com -- Shares of the pharmaceutical companyTorrent Pharmaceuticals (NS:TORP) tanked 15.4% to Rs 2,673.5 apiece at 11:40 am on Thursday, after diving over 16%...
-
Alembic Pharma Rose Over 4% After USFDA Nod; Nifty Pharma Ends in Red
By Malvika Gurung Investing.com -- The Gujarat-based pharmaceutical company Alembic Pharmaceuticals Ltd (NS:ALEM) received approval from the US health regulator US Food and Drug...
-
Gland Pharma Soars 9.19% to Close at 52-Week High After Q4 Results
By Aditya Raghunath Investing.com -- Shares of Gland Pharma Ltd (NS:GLAD) closed at Rs 3,050 today after it reported its numbers for the March quarter of 2021. It reported a 34% increase in...
-
Panacea Biotec Zooms 19% After News that it Will Produce Sputnik V Vaccine
By Aditya Raghunath Investing.com -- Shares of New Delhi-based pharma company Panacea Biotec Ltd (NS:PNCA) are up 19.14% as of this report after news broke last evening, after market...
-
UPDATE 2-India's Stelis Biopharma to make 200 mln doses of Sputnik V vaccine
(Adds details from deal, quote, background)BENGALURU, March 19 (Reuters) - India's Stelis Biopharma has partnered with Russia's sovereign fund to make at least 200 million doses of Sputnik...
-
CORRECTED-UPDATE 1-India's Stelis Biopharma to make 200 mln doses of Sputnik V vaccine
(Corrects figure in paragraph 1 to "half a billion", from "half a million")BENGALURU, March 19 (Reuters) - Indian drugmaker Strides Pharma Science SRID.NS said on Friday its unit Stelis...
-
UPDATE 2-India's Gland Pharma to make up to 252 mln Sputnik V vaccine doses
(Adds details on vaccine, background)BENGALURU, March 16 (Reuters) - Gland Pharma Ltd GLAD.NS said on Tuesday it had struck a deal with the Russian Direct Investment Fund (RDIF) to make up...
-
Indian shares end lower as banks drag; Gland Pharma jumps 10% on vaccine deal
By Sethuraman N RBENGALURU, March 16 (Reuters) - Indian shares gave up early gains to close lower on Tuesday, dragged down by losses in financial stocks, while Gland Pharma jumped as much...
-
India's Gland Pharma to produce, supply up to 252 mln Sputnik V vaccine doses
BENGALURU, March 16 (Reuters) - India's Gland Pharma Ltd GLAD.NS said on Tuesday it has entered into an agreement with the Russian Direct Investment Fund to produce and supply up to 252...
-
Why Gland Pharma is Getting Recommended by Brokerages
By Aditya Raghunath Investing.com -- If you take a look at Gland Pharma Ltd's (NS:GLAD) share price from December 1, 2020, you’ll see a slight upward trend in the stock. It just kept going...
-
BRIEF-India's Gland Pharma Dec-Quarter Profit Rises
Jan 22 (Reuters) - Gland Pharma Ltd GLAD.NS :* INDIA'S GLAND PHARMA LTD DEC-QUARTER PROFIT 2.04 BILLION RUPEES VERSUS 1.54 BILLION RUPEES YEAR AGO* GLAND PHARMA LTD DEC-QUARTER REVENUE...
-
How the IPO Market Fared in 2020
By Aditya Raghunath Investing.com -- As Antony Waste Handling Cell Ltd (NS:ANTONY) makes its debut on Indian indices today, the first day of 2021, let’s take a look at how 2020 treated...
-
Should You Subscribe to Antony Waste Handling’s IPO?
By Aditya Raghunath Investing.com -- Solid waste management company Antony Waste Handling Cell is coming out with its second attempt at an IPO in 2020. The company will open up its offer for...
-
Why Laurus Labs Zoomed 365% in Eight Months
By Aditya Raghunath Investing.com -- Every crisis brings opportunity. While a lot of businesses have cracked under the pressure of the COVID-19 pandemic, Hyderabad-based Laurus Labs Ltd...
-
Gland Pharma Closes IPO Debut 22% Higher From Listing Price
By Aditya Raghunath Investing.com -- It’s hard to believe that Gland Pharma Ltd (NS:GLAD) struggled to get retail subscriptions for the first two days of its IPO offering. The scrip made its...
-
Indian shares end higher on boost from financials
BENGALURU, Nov 20 (Reuters) - Indian shares bounced back on Friday from a sharp fall in the previous session, taking their cue from an advance in global markets and driven by signs of a...
-
UPDATE 2-India's Gland Pharma jumps 23% in market debut
(Adds book runners, analyst quote)By Anuron Kumar MitraBENGALURU, Nov 20 (Reuters) - Shares of India's Gland Pharma GLAD.NS got off to a flying start in their market debut on Friday,...
-
CORRECTED-India's Gland Pharma jumps 20% in market debut
(Corrects amount raised in IPO to "64.80 billion rupees" from "73.87 billion rupees" in paragraph 1)BENGALURU, Nov 20 (Reuters) - Shares of India's Gland Pharma GLAD.NS rose as much as 20%...
-
Nifty bounce as consumer shares rise
By Sachin Ravikumar BENGALURU, Nov 20 (Reuters) - Indian shares rose on Friday after a sharp fall in the previous session, taking their cue from a stronger finish on Wall Street and driven...
-
Nifty rebound as financials rise
BENGALURU, Nov 20 (Reuters) - Indian shares clocked broad-based gains on Friday, rebounding from a sharp fall in the previous session in the backdrop of improving economic growth...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
